You have free access to this content

Hepatology

Cover image for Hepatology

February 2009

Volume 49, Issue 2

Pages 339–707

  1. Obituary

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
  2. Comments from the Editors

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      A new section: Image of the month (page 344)

      Keith D. Lindor

      Version of Record online: 22 DEC 2008 | DOI: 10.1002/hep.22803

  3. Editorials

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
  4. Viral Hepatitis

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection (pages 358–363)

      Alessandra Mangia, Nicola Minerva, Donato Bacca, Raffaele Cozzolongo, Ernesto Agostinacchio, Fernando Sogari, Gaetano Scotto, Francesco Vinelli, Giovanni Luciano Ricci, Mario Romano, Vito Carretta, Daniela Petruzzellis and Angelo Andriulli

      Version of Record online: 9 OCT 2008 | DOI: 10.1002/hep.22679

    2. You have free access to this content
      Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs (pages 364–377)

      Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, Jacob B. Lademann, Jannick C. Prentoe, Maria L. Knudsen, Anne M. Hoegh and Jens Bukh

      Version of Record online: 9 OCT 2008 | DOI: 10.1002/hep.22673

    3. You have free access to this content
      In vitro–targeted gene identification in patients with hepatitis C using a genome-wide microarray technology (pages 378–386)

      Susanne Hagist, Holger Sültmann, Gunda Millonig, Ulrike Hebling, Dörthe Kieslich, Rupert Kuner, Sabrina Balaguer, Helmut-Karl Seitz, Annemarie Poustka and Sebastian Mueller

      Version of Record online: 14 OCT 2008 | DOI: 10.1002/hep.22677

    4. You have free access to this content
      The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis (pages 387–397)

      Itay Shalev, Kit Man Wong, Katharina Foerster, Yi Zhu, Cecilia Chan, Asif Maknojia, Jianhua Zhang, Xue-Zhong Ma, Xiao Chun Yang, Julia Fang Gao, Hao Liu, Nazia Selzner, David A. Clark, Oyedele Adeyi, M. James Phillips, Reginald R. Gorczynski, David Grant, Ian McGilvray and Gary Levy

      Version of Record online: 14 OCT 2008 | DOI: 10.1002/hep.22684

    5. You have free access to this content
      Hepatitis delta virus inhibits alpha interferon signaling (pages 398–406)

      Paolo Pugnale, Valerio Pazienza, Kévin Guilloux and Francesco Negro

      Version of Record online: 26 SEP 2008 | DOI: 10.1002/hep.22654

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist (pages 407–417)

      Edward E. Cable, Patricia D. Finn, Jeffrey W. Stebbins, Jinzhao Hou, Bruce R. Ito, Paul D. van Poelje, David L. Linemeyer and Mark D. Erion

      Version of Record online: 13 AUG 2008 | DOI: 10.1002/hep.22572

    2. You have free access to this content
      Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis (pages 418–425)

      Darrell H. G. Crawford, Therese L. Murphy, Louise E. Ramm, Linda M. Fletcher, Andrew D. Clouston, Gregory J. Anderson, V. Nathan Subramaniam, Lawrie W. Powell and Grant A. Ramm

      Version of Record online: 22 SEP 2008 | DOI: 10.1002/hep.22650

    3. You have free access to this content
      Transcription factor 7–like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH (pages 426–435)

      Giovanni Musso, Roberto Gambino, Giovanni Pacini, Gianfranco Pagano, Marilena Durazzo and Maurizio Cassader

      Version of Record online: 26 SEP 2008 | DOI: 10.1002/hep.22659

    4. You have free access to this content
      Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy (pages 436–442)

      Patrick Ingiliz, Marc-Antoine Valantin, Claudine Duvivier, Fadia Medja, Stephanie Dominguez, Frédéric Charlotte, Roland Tubiana, Thierry Poynard, Christine Katlama, Anne Lombès and Yves Benhamou

      Version of Record online: 10 DEC 2008 | DOI: 10.1002/hep.22665

    5. You have free access to this content
  6. Hepatobiliary Malignancies

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies (pages 453–459)

      Yun Ku Cho, Jae Kyun Kim, Mi Young Kim, Hyunchul Rhim and Joon Koo Han

      Version of Record online: 22 SEP 2008 | DOI: 10.1002/hep.22648

    2. You have free access to this content
      Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma (pages 460–470)

      Dou-Sheng Bai, Zhi Dai, Jian Zhou, Yin-Kun Liu, Shuang-Jian Qiu, Chang-Jun Tan, Ying-Hong Shi, Cheng Huang, Zheng Wang, Yi-Feng He and Jia Fan

      Version of Record online: 19 SEP 2008 | DOI: 10.1002/hep.22638

    3. You have free access to this content
      Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down-modulation (pages 471–481)

      Jasmin T. Ney, Thomas Schmidt, Christian Kurts, Qi Zhou, Dawid Eckert, Dean W. Felsher, Hubert Schorle, Percy Knolle, Thomas Tüting, Winfried Barchet, Reinhard Büttner, Andreas Limmer and Ines Gütgemann

      Version of Record online: 22 SEP 2008 | DOI: 10.1002/hep.22652

    4. You have free access to this content
      Blocking the hedgehog pathway inhibits hepatoblastoma growth (pages 482–490)

      Melanie Eichenmüller, Ivonne Gruner, Beate Hagl, Beate Häberle, Josef Müller-Höcker, Dietrich von Schweinitz and Roland Kappler

      Version of Record online: 22 SEP 2008 | DOI: 10.1002/hep.22649

    5. You have free access to this content
      Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma (pages 491–503)

      Ai-Wu Ke, Guo-Ming Shi, Jian Zhou, Fei-Zhen Wu, Zhen-Bin Ding, Mei-Yu Hu, Yang Xu, Zheng-Ji Song, Zhi-Jun Wang, Jin-Cai Wu, Dou-Sheng Bai, Jia-chu Li, Kang-Da Liu and Jia Fan

      Version of Record online: 19 SEP 2008 | DOI: 10.1002/hep.22639

    6. You have free access to this content
      Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner (pages 504–512)

      Zhi Zhu, Zhigang Luo, Yongmei Li, Canrong Ni, Honghua Li and Minghua Zhu

      Version of Record online: 9 OCT 2008 | DOI: 10.1002/hep.22675

    7. You have free access to this content
      Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis (pages 513–522)

      Yutaka Midorikawa, Shogo Yamamoto, Shingo Tsuji, Naoko Kamimura, Shumpei Ishikawa, Hisaki Igarashi, Masatoshi Makuuchi, Norihiro Kokudo, Haruhiko Sugimura and Hiroyuki Aburatani

      Version of Record online: 24 OCT 2008 | DOI: 10.1002/hep.22698

    8. You have free access to this content
      Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice (pages 523–532)

      Sven A. Lang, Christian Moser, Stefan Fichnter-Feigl, Philipp Schachtschneider, Claus Hellerbrand, Volker Schmitz, Hans J. Schlitt, Edward K. Geissler and Oliver Stoeltzing

      Version of Record online: 14 OCT 2008 | DOI: 10.1002/hep.22685

  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Fibrogenesis in pediatric cholestatic liver disease: Role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment (pages 533–544)

      Grant A. Ramm, Ross W. Shepherd, Anita C. Hoskins, Sonia A. Greco, Agnieszka D. Ney, Tamara N. Pereira, Kim R. Bridle, James D. Doecke, Peter J. Meikle, Bruno Turlin and Peter J. Lewindon

      Version of Record online: 19 SEP 2008 | DOI: 10.1002/hep.22637

    2. You have free access to this content
      Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis (pages 545–552)

      Weici Zhang, Rahul Sharma, Shyr-Te Ju, Xiao-Song He, Yanyan Tao, Koichi Tsuneyama, Zhigang Tian, Zhe-Xiong Lian, Shu Man Fu and M. Eric Gershwin

      Version of Record online: 22 SEP 2008 | DOI: 10.1002/hep.22651

    3. You have free access to this content
      Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing (pages 553–567)

      Jane A. Byrne, Sandra S. Strautnieks, Gudrun Ihrke, Franco Pagani, A.S. Knisely, Kenneth J. Linton, Giorgina Mieli-Vergani and Richard J. Thompson

      Version of Record online: 14 OCT 2008 | DOI: 10.1002/hep.22683

  8. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Predicting in-hospital mortality in patients with cirrhosis: Results differ across risk adjustment methods (pages 568–577)

      Robert P. Myers, Hude Quan, James N. Hubbard, Abdel Aziz M. Shaheen and Gilaad G. Kaplan

      Version of Record online: 9 OCT 2008 | DOI: 10.1002/hep.22676

    2. You have free access to this content
      Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function (pages 578–586)

      Colleen M. Brophy, Jennifer L. Luebke-Wheeler, Bruce P. Amiot, Harris Khan, Rory P. Remmel, Piero Rinaldo and Scott L. Nyberg

      Version of Record online: 9 OCT 2008 | DOI: 10.1002/hep.22674

    3. You have free access to this content
      Recruitment of host progenitor cells in rat liver transplants (pages 587–597)

      Zhaoli Sun, Xiuying Zhang, Jayme E. Locke, Qizhi Zheng, Shingo Tachibana, Anna Mae Diehl and George Melville Williams

      Version of Record online: 22 SEP 2008 | DOI: 10.1002/hep.22653

  9. Liver Injury/Regeneration

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Alanine aminotransferase isoenzymes: Molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity (pages 598–607)

      Rong-Ze Yang, Soohyun Park, William J. Reagan, Rick Goldstein, Shao Zhong, Michael Lawton, Francis Rajamohan, Kun Qian, Li Liu and Da-Wei Gong

      Version of Record online: 26 SEP 2008 | DOI: 10.1002/hep.22657

    2. You have free access to this content
      Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation (pages 608–617)

      Mercedes Vázquez-Chantada, Usue Ariz, Marta Varela-Rey, Nieves Embade, Nuria Martínez-Lopez, David Fernández-Ramos, Laura Gómez-Santos, Santiago Lamas, Shelly C. Lu, M. Luz Martínez-Chantar and José M. Mato

      Version of Record online: 26 SEP 2008 | DOI: 10.1002/hep.22660

  10. Liver Biology/Pathobiology

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Hepatic function is preserved in the absence of mature microRNAs (pages 618–626)

      Nicholas J. Hand, Zankhana R. Master, John Le Lay and Joshua R. Friedman

      Version of Record online: 26 SEP 2008 | DOI: 10.1002/hep.22656

    2. You have free access to this content
      Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes (pages 627–636)

      Binje Vick, Achim Weber, Toni Urbanik, Thorsten Maass, Andreas Teufel, Peter H. Krammer, Joseph T. Opferman, Marcus Schuchmann, Peter R. Galle and Henning Schulze-Bergkamen

      Version of Record online: 19 NOV 2008 | DOI: 10.1002/hep.22664

    3. You have free access to this content
      Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice (pages 637–645)

      Nora Bijl, Cindy P. A. A. van Roomen, Vassilis Triantis, Milka Sokolovic, Roelof Ottenhoff, Saskia Scheij, Marco van Eijk, Rolf G. Boot, Johannes M. Aerts and Albert K. Groen

      Version of Record online: 19 NOV 2008 | DOI: 10.1002/hep.22663

    4. You have free access to this content
      The interleukin-17 pathway is involved in human alcoholic liver disease (pages 646–657)

      Arnaud Lemmers, Christophe Moreno, Thierry Gustot, Raphaël Maréchal, Delphine Degré, Pieter Demetter, Patricia de Nadai, Albert Geerts, Eric Quertinmont, Vincent Vercruysse, Olivier Le Moine and Jacques Devière

      Version of Record online: 9 OCT 2008 | DOI: 10.1002/hep.22680

  11. Special Article

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
  12. Reviews

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Occult hepatitis C: How convincing are the current data? (pages 665–675)

      Martin-Walter Welker and Stefan Zeuzem

      Version of Record online: 24 OCT 2008 | DOI: 10.1002/hep.22706

    2. You have free access to this content
      Chemokines in the immunopathogenesis of hepatitis C infection (pages 676–688)

      Mathis Heydtmann and David H. Adams

      Version of Record online: 2 DEC 2008 | DOI: 10.1002/hep.22763

  13. Hepatology Elsewhere

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
      Insights into defibrotide as therapy for veno-occlusive disease (pages 689–690)

      Jennifer R. Gamble and Mathew A. Vadas

      Version of Record online: 5 JAN 2009 | DOI: 10.1002/hep.22770

    2. You have free access to this content
      Kupffer cells and hepatocyte metabolism: A two-way street? (pages 690–692)

      Elizabeth E. Powell, Michael J. Waters and Julie R. Jonsson

      Version of Record online: 6 JAN 2009 | DOI: 10.1002/hep.22801

    3. You have free access to this content
      The genes that underlie fatty liver disease: The harvest has begun (pages 692–694)

      Ralf Weiskirchen and Hermann E. Wasmuth

      Version of Record online: 6 JAN 2009 | DOI: 10.1002/hep.22800

  14. Image of the Month

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
  15. Correspondence

    1. Top of page
    2. Obituary
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Article
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Reply: (page 697)

      Anna Ludovica Fracanzani, Luca Valenti and Silvia Fargion

      Version of Record online: 2 DEC 2008 | DOI: 10.1002/hep.22762

    3. You have free access to this content
    4. You have free access to this content
      Reply: (page 698)

      Julia L. Newton

      Version of Record online: 30 DEC 2008 | DOI: 10.1002/hep.22784

    5. You have free access to this content
      Hepatitis B virus viral load and treatment decision (page 699)

      Hans Tillmann, Keyur Patel and John McHutchison

      Version of Record online: 25 NOV 2008 | DOI: 10.1002/hep.22755

    6. You have free access to this content
    7. You have free access to this content
      Do guidelines preclude hepatitis B patients from receiving treatment? (pages 700–701)

      Bulent Degertekin and Anna S. Lok

      Version of Record online: 13 NOV 2008 | DOI: 10.1002/hep.22722

    8. You have free access to this content
      Reply: (pages 701–702)

      Myron John Tong, Carlos Hsien, Leeyen Hsu, Hai-En Sun and Lawrence M. Blatt

      Version of Record online: 30 DEC 2008 | DOI: 10.1002/hep.22768

    9. You have free access to this content
      The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: Should we utilize more?

      Alessio Aghemo, Maria Grazia Rumi, Gian Maria Prati and Massimo Colombo

      Version of Record online: 28 JAN 2009 | DOI: 10.1002/hep.22732

    10. You have free access to this content
      Reply: (pages 703–704)

      Peter Ferenci

      Version of Record online: 11 DEC 2008 | DOI: 10.1002/hep.22782

    11. You have free access to this content
    12. You have free access to this content
      Reply: (pages 705–706)

      George V. Papatheodoridis, Emanuel K. Manesis, Spilios Manolakopoulos, Ioannis S. Elefsiniotis, John Goulis and Athanasios J. Archimandritis

      Version of Record online: 11 DEC 2008 | DOI: 10.1002/hep.22780

    13. You have free access to this content

SEARCH

SEARCH BY CITATION